The Risks of Compounded Semaglutide Lack of FDA Approval and Regulation One of the most critical distinctions between compounded semaglutide and its FDA-approved counterparts is the lack of regulatory oversight
Suster S, Ronnen M, Bubis JJ
Diabetes Control For our patients with type 2 diabetes, Semaglutide GLP-1 can offer a valuable tool to help manage their blood sugar levels
However, compounded semaglutide is not an FDA-approved finished product, is not an FDA-approved generic, and has not been evaluated by FDA for safety, effectiveness, or quality as a finished product
Symptoms of a haemolytic episode including dark urine, jaundice, and sudden fatigue require urgent medical review
But is it better than CoolSculpting